Te Boekhorst Paul Francis Olivier Insider Trades & Stock Holdings

President and CEO · ImmuCell Corporation · Latest filing Jun 18, 2026

Te Boekhorst Paul Francis Olivier, President and CEO at ImmuCell Corporation has 2 Form 4 trades on file since Jun 18, 2026. Open-market activity: 2 purchases ($152K) and 0 sales ($0), net +$152K. Latest filing: acquired 8K shares of $ICCC on Jun 18, 2026 at $9.50.

Trades on file

2

Open-market bought

$152K

Open-market sold

$0

Net open-market

+$152K

Latest filing

Jun 18, 2026

All insider trades by Te Boekhorst Paul Francis Olivier

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$ICCC	Buy (Open-market buy)	8K	$9.50	$76K			+4.2%	+17.5%		President and CEO		Read
Jun 18, 2026	$ICCC	Buy (Open-market buy)	8K	$9.50	$76K			+4.2%	+17.5%		President and CEO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Te Boekhorst Paul Francis Olivier traded

• $ICCC

Frequently asked questions

Has Te Boekhorst Paul Francis Olivier been buying or selling stock?

Te Boekhorst Paul Francis Olivier has 2 open-market purchases and 0 open-market sales on file, net +$152K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Te Boekhorst Paul Francis Olivier's latest insider trade?

acquired 8K shares of $ICCC on Jun 18, 2026 at $9.50.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.